XML 39 R21.htm IDEA: XBRL DOCUMENT v3.2.0.727
Liquidity Risks and Management's Plans (Details)
$ / shares in Units, $ in Thousands
6 Months Ended
Jul. 29, 2015
USD ($)
Jul. 22, 2015
USD ($)
Amendment
$ / shares
shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Jul. 09, 2015
USD ($)
Dec. 31, 2014
USD ($)
shares
Jun. 30, 2014
USD ($)
Dec. 31, 2013
USD ($)
Liquidity Risks and Management's Plans [Abstract]              
Cash and cash equivalents     $ 26,091   $ 44,711 $ 65,557 $ 86,283
Long-term debt     30,000   $ 30,000    
Liquidity Risk and Managements Plans [Line Items]              
Prepayment of principal amount of loan outstanding     $ 10,000        
Cash interest rate under loan facility (in hundredths)     8.75%        
Market price of common stock (in dollars per share) | $ / shares     $ 1.00        
Number of days below market price threshold     30 days        
Number of days required to remain above market price threshold     10 days        
Number of days to achieve compliance after delisting notice     180 days        
Number of days of extension based upon criteria met     180 days        
Number of warrant shares potentially issuable (in shares) | shares     13,200,000        
Common stock, shares authorized (in shares) | shares     250,000,000   250,000,000    
Common stock available for future issuance (in shares) | shares     136,000,000        
Deerfield Management Company [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Exercise price of warrants (in dollars per share) | $ / shares     $ 2.81        
Number of warrant shares potentially issuable (in shares) | shares     7,000,000        
ATM Program [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Maximum value of potential common stock available for issue     $ 23,000        
Percentage sales commission on shares (in hundredths)     3.00%        
Battelle - 2014 Collaboration Agreement [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Research and development, expected planned cost for stage 2 and 3     $ 6,000        
Research and development, percentage of expected planned cost for stage 2 and 3 (in hundredths)     50.00%        
Deferred payments interest bearing threshold     90 days        
Deferred payments, outstanding interest rate (in hundredths)     12.00%        
Deferred payments deferment limit, period     30 days        
Deferred costs     $ 1,500        
Maximum period to defer payment     12 months        
Battelle - 2014 Collaboration Agreement [Member] | Maximum [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Research and development, planned cost for stage 2 and 3     $ 11,850        
Expected deferred payments amount     $ 4,000        
Subsequent Event [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Gross proceeds from issuance of common stock   $ 40,250          
Net proceeds from issuance of common stock   37,600          
Non-cash consideration received   $ 5,000          
Common stock, shares authorized (in shares) | shares   250,000,000          
Common stock issued and outstanding or reserved for future issuance (in shares) | shares   246,900,000          
Subsequent Event [Member] | Deerfield Management Company [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Prepayment of principal amount of loan outstanding   $ 5,000          
Subsequent Event [Member] | Deerfield Debt Restructuring [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Prepayment of principal amount of loan outstanding $ 12,500 5,000          
Principal amount of loan outstanding payable in February 2018   12,500   $ 12,500      
Principal amount of loan outstanding payable in February 2019   12,500   $ 12,500      
Investments in public offering   5,000          
Prepayment of future interest obligations   $ 5,000          
Cash interest rate under loan facility (in hundredths)   8.25%          
Number of amendments to loan agreement | Amendment   2          
Non-cash consideration received   $ 5,000          
Series A and B Units [Member] | Subsequent Event [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Number of warrants issued (in shares) | shares   67,100,000          
Exercise price of warrants (in dollars per share) | $ / shares   $ 0.70          
Series A Units [Member] | Subsequent Event [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Sale of unit price per unit (in dollars per share) | $ / shares   $ 0.60          
Series B Units [Member] | Subsequent Event [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Number of warrants issued (in shares) | shares   42,000,000          
Number of warrants required to purchase one share of common stock (in shares) | shares   1          
Sale of unit price per unit (in dollars per share) | $ / shares   $ 0.60          
February 2011 Warrants [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Exercise price of warrants (in dollars per share) | $ / shares     $ 1.50        
Number of warrant shares potentially issuable (in shares) | shares     4,600,000        
Warrants expiration date     Feb. 22, 2016        
February 2011 Warrants [Member] | Maximum [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Potential proceeds of warrants if exercised     $ 900        
February 2011 Warrants [Member] | Subsequent Event [Member]              
Liquidity Risk and Managements Plans [Line Items]              
Exercise price of warrants (in dollars per share) | $ / shares   $ 0.19